Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration

Abstract Introduction Azithromycin demonstrates high tissue distribution and prolonged elimination half-life. In this study, we monitored the pharmacokinetics of a single ophthalmic administration of 1% azithromycin ophthalmic solution containing polycarbophil in the extraocular tissues, including t...

Full description

Bibliographic Details
Main Authors: Tatsuya Sakai, Keisuke Shinno, Masaaki Kurata, Akio Kawamura
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-08-01
Series:Ophthalmology and Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1007/s40123-019-00205-0
id doaj-8d94c9fa313e40fca35a37115d6792ce
record_format Article
spelling doaj-8d94c9fa313e40fca35a37115d6792ce2020-11-25T02:37:15ZengAdis, Springer HealthcareOphthalmology and Therapy2193-82452193-65282019-08-018451151710.1007/s40123-019-00205-0Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic AdministrationTatsuya Sakai0Keisuke Shinno1Masaaki Kurata2Akio Kawamura3Research and Development Division, Senju Pharmaceutical Co., Ltd.Research and Development Division, Senju Pharmaceutical Co., Ltd.Research and Development Division, Senju Pharmaceutical Co., Ltd.Research and Development Division, Senju Pharmaceutical Co., Ltd.Abstract Introduction Azithromycin demonstrates high tissue distribution and prolonged elimination half-life. In this study, we monitored the pharmacokinetics of a single ophthalmic administration of 1% azithromycin ophthalmic solution containing polycarbophil in the extraocular tissues, including the eyelid, and compared it with that of two commercial ophthalmic products, 1.5% levofloxacin ophthalmic solution and 0.3% ofloxacin ophthalmic ointment. Methods Rabbits were treated with either a single topical administration of 1% azithromycin ophthalmic solution, 1.5% levofloxacin ophthalmic solution, or 0.3% ofloxacin ophthalmic ointment. The eyelid, conjunctiva, and cornea were collected at 0.25, 0.5, 1, 2, 4, 8, and 24 h post-administration. Tissue samples were pretreated for drug concentration measurements by ultra-performance liquid chromatography-tandem mass spectrometry. Pharmacokinetic parameters were determined by non-compartmental analysis. Results Azithromycin was rapidly absorbed, and its levels remained near the observed maximum concentrations for up to 24 h post-administration in all tissue. In contrast, extraocular tissue concentrations of levofloxacin and ofloxacin decreased with time. The maximum concentrations of azithromycin, levofloxacin, and ofloxacin were 35.6, 34.1, and 55.1 µg/g in the eyelid, 44.2, 46.8, and 20.4 µg/g in the conjunctiva, and 79.9, 18.0, and 2.21 µg/g in the cornea, respectively. The values of the area under the curve from 0 to 24 h after administration of azithromycin, levofloxacin, and ofloxacin were 602, 58.5, and 267 µg·h/g in the eyelid, 837, 43.2, and 51.9 µg·h/g in the conjunctiva, and 1250, 26.4, and 5.46 µg h/g in the cornea, respectively. Conclusion The drug concentrations of azithromycin and levofloxacin were relatively comparable among the extraocular tissues following topical administration of the respective ophthalmic solutions, whereas the concentrations of ofloxacin varied following dosing of its ophthalmic ointment. The slow elimination profile in any extraocular tissue of rabbits was unique to azithromycin, and led to the demonstration of high exposures of azithromycin in all extraocular tissues after ophthalmic administration. Funding This research and Rapid Service Fees were supported by Senju Pharmaceutical Co., Ltd.http://link.springer.com/article/10.1007/s40123-019-00205-0AzithromycinConjunctivaCorneaDrug concentration profileEyelidLevofloxacin
collection DOAJ
language English
format Article
sources DOAJ
author Tatsuya Sakai
Keisuke Shinno
Masaaki Kurata
Akio Kawamura
spellingShingle Tatsuya Sakai
Keisuke Shinno
Masaaki Kurata
Akio Kawamura
Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration
Ophthalmology and Therapy
Azithromycin
Conjunctiva
Cornea
Drug concentration profile
Eyelid
Levofloxacin
author_facet Tatsuya Sakai
Keisuke Shinno
Masaaki Kurata
Akio Kawamura
author_sort Tatsuya Sakai
title Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration
title_short Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration
title_full Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration
title_fullStr Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration
title_full_unstemmed Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration
title_sort pharmacokinetics of azithromycin, levofloxacin, and ofloxacin in rabbit extraocular tissues after ophthalmic administration
publisher Adis, Springer Healthcare
series Ophthalmology and Therapy
issn 2193-8245
2193-6528
publishDate 2019-08-01
description Abstract Introduction Azithromycin demonstrates high tissue distribution and prolonged elimination half-life. In this study, we monitored the pharmacokinetics of a single ophthalmic administration of 1% azithromycin ophthalmic solution containing polycarbophil in the extraocular tissues, including the eyelid, and compared it with that of two commercial ophthalmic products, 1.5% levofloxacin ophthalmic solution and 0.3% ofloxacin ophthalmic ointment. Methods Rabbits were treated with either a single topical administration of 1% azithromycin ophthalmic solution, 1.5% levofloxacin ophthalmic solution, or 0.3% ofloxacin ophthalmic ointment. The eyelid, conjunctiva, and cornea were collected at 0.25, 0.5, 1, 2, 4, 8, and 24 h post-administration. Tissue samples were pretreated for drug concentration measurements by ultra-performance liquid chromatography-tandem mass spectrometry. Pharmacokinetic parameters were determined by non-compartmental analysis. Results Azithromycin was rapidly absorbed, and its levels remained near the observed maximum concentrations for up to 24 h post-administration in all tissue. In contrast, extraocular tissue concentrations of levofloxacin and ofloxacin decreased with time. The maximum concentrations of azithromycin, levofloxacin, and ofloxacin were 35.6, 34.1, and 55.1 µg/g in the eyelid, 44.2, 46.8, and 20.4 µg/g in the conjunctiva, and 79.9, 18.0, and 2.21 µg/g in the cornea, respectively. The values of the area under the curve from 0 to 24 h after administration of azithromycin, levofloxacin, and ofloxacin were 602, 58.5, and 267 µg·h/g in the eyelid, 837, 43.2, and 51.9 µg·h/g in the conjunctiva, and 1250, 26.4, and 5.46 µg h/g in the cornea, respectively. Conclusion The drug concentrations of azithromycin and levofloxacin were relatively comparable among the extraocular tissues following topical administration of the respective ophthalmic solutions, whereas the concentrations of ofloxacin varied following dosing of its ophthalmic ointment. The slow elimination profile in any extraocular tissue of rabbits was unique to azithromycin, and led to the demonstration of high exposures of azithromycin in all extraocular tissues after ophthalmic administration. Funding This research and Rapid Service Fees were supported by Senju Pharmaceutical Co., Ltd.
topic Azithromycin
Conjunctiva
Cornea
Drug concentration profile
Eyelid
Levofloxacin
url http://link.springer.com/article/10.1007/s40123-019-00205-0
work_keys_str_mv AT tatsuyasakai pharmacokineticsofazithromycinlevofloxacinandofloxacininrabbitextraoculartissuesafterophthalmicadministration
AT keisukeshinno pharmacokineticsofazithromycinlevofloxacinandofloxacininrabbitextraoculartissuesafterophthalmicadministration
AT masaakikurata pharmacokineticsofazithromycinlevofloxacinandofloxacininrabbitextraoculartissuesafterophthalmicadministration
AT akiokawamura pharmacokineticsofazithromycinlevofloxacinandofloxacininrabbitextraoculartissuesafterophthalmicadministration
_version_ 1724795828815527936